Table 3 Multivariate linear regression models for the total NSCLC treatment cost logarithm – INCA, 2011 (n = 251)
From: “Factors associated with non-small cell lung cancer treatment costs in a Brazilian public hospital”
Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | |
|---|---|---|---|---|---|---|
Age at diagnosis | −0.013 (0.005) *** | − 0.011 (0.005) ** | − 0.011 (0.005) ** | −0.010 (0.005) ** | − 0.007 (0.004) | −0.004 (0.003) |
Man | 0.069 (0.095) | 0.044 (0.096) | 0.058 (0.100) | 0.059 (0.097) | 0.068 (0.077) | 0.039 (0.064) |
Color/race (reference: White) | ||||||
Black | −0.027 (0.202) | −0.025 (0.202) | − 0.005 (0.203) | −0.017 (0.196) | − 0.019 (0.155) | 0.044 (0.128) |
Mixed | −0.054 (0.094) | −0.022 (0.094) | − 0.017 (0.094) | 0.004 (0.090) | 0.026 (0.071) | 0.012 (0.059) |
Marital Status (reference: Married/Consensual Union) | ||||||
Divorced/Separated | 0.257 (0.159) | 0.231 (0.160) | 0.227 (0.162) | 0.243 (0.156) | 0.163 (0.124) | 0.179 (0.104) |
Widower | 0.155 (0.161) | 0.177 (0.161) | 0.190 (0.162) | 0.169 (0.156) | 0.241 (0.123) | 0.117 (0.104) |
Single | −0.057 (0.122) | −0.035 (0.121) | −0.025 (0.121) | 0.028 (0.118) | 0.064 (0.093) | 0.030 (0.077) |
Education (reference: Illiterate) | ||||||
Elementary – Incomplete | 0.456 (0.193) ** | 0.429 (0.196) ** | 0.462 (0.189) ** | 0.235 (0.149) | 0.191 (0.124) | |
Elementary – Complete | 0.444 (0.202) ** | 0.441 (0.205) ** | 0.407 (0.198) ** | 0.222 (0.157) | 0.162 (0.130) | |
High School – Complete | 0.503 (0.222) ** | 0.489 (0.225) ** | 0.479 (0.219) ** | 0.272 (0.174) | 0.249 (0.144) | |
Higher Education – Complete | 0.705 (0.260) *** | 0.700 (0.261) *** | 0.799 (0.253) *** | 0.514 (0.200) ** | 0.408 (0.166) ** | |
Alcohol consumption (reference: No) | ||||||
Yes | 0.031 (0.094) | 0.028 (0.092) | 0.049 (0.072) | 0.004 (0.060) | ||
Ignored | −0.216 (0.209) | −0.208 (0.203) | −0.181 (0.159) | −0.149 (0.133) | ||
Tobacco use history | −0.260 (0.146) | −0.243 (0.141) | − 0.289 (0.111) ** | −0.143 (0.095) | ||
With comorbidity | 0.085 (0.085) | 0.017 (0.068) | −0.037 (0.056) | |||
Performance Status (reference: PS 0) | ||||||
PS 1 | −0.064 (0.129) | −0.065 (0.101) | − 0.018 (0.086) | |||
PS2 | −0.441 (0.139) *** | −0.322 (0.110) *** | − 0.148 (0.096) | |||
Staging IV | −0.183 (0.089) ** | −0.111 (0.071) | − 0.009 (0.060) | |||
Hospitalization | 0.431 (0.068) *** | 0.631 (0.061) *** | ||||
Chemotherapy/Radiotherapy | 0.923 (0.097) *** | 0.734 (0.084) *** | ||||
Death period (reference: less than 3 months) | ||||||
From 3 to 6 months | 0.036 (0.082) | |||||
From 6 to 9 months | 0.259 (0.095) *** | |||||
From 9 to 12 months | 0.331 (0.105) *** | |||||
From 12 to 18 months | 0.362 (0.103) *** | |||||
Over 18 months | 0.951 (0.102) *** | |||||
Constant | 5.866 (0.287) *** | 5.280 (0.366) *** | 5.517 (0.388) *** | 5.705 (0.401) *** | 4.574 (0.329) *** | 4.067 (0.279) *** |
Adjusted R2 | 0.016 | 0.032 | 0.038 | 0.111 | 0.449 | 0.622 |